F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Short Interest Update

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) saw a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 11,453 shares, a decline of 48.0% from the July 15th total of 22,041 shares. Based on an average daily trading volume, of 4,707 shares, the days-to-cover ratio is currently 2.4 days. Currently, 0.4% of the company’s shares are short sold.

F/m Emerald Life Sciences Innovation ETF Trading Up 0.6%

Shares of LFSC traded up $0.27 on Friday, reaching $47.09. 2,228 shares of the company’s stock were exchanged, compared to its average volume of 4,720. The business has a 50 day moving average price of $44.58 and a two-hundred day moving average price of $39.27. F/m Emerald Life Sciences Innovation ETF has a 12 month low of $26.75 and a 12 month high of $47.68.

Institutional Trading of F/m Emerald Life Sciences Innovation ETF

A hedge fund recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC grew its stake in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 49,739 shares of the company’s stock after purchasing an additional 3,831 shares during the quarter. Hunter Associates Investment Management LLC owned about 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 at the end of the most recent reporting period.

F/m Emerald Life Sciences Innovation ETF Company Profile

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.